Titre : Refus du traitement

Refus du traitement : Questions médicales fréquentes

Termes MeSH sélectionnés :

Microarray Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Refus du traitement : Questions médicales les plus fréquentes", "headline": "Refus du traitement : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Refus du traitement : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Refus du traitement" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Adhésion et observance thérapeutiques", "url": "https://questionsmedicales.fr/mesh/D000074822", "about": { "@type": "MedicalCondition", "name": "Adhésion et observance thérapeutiques", "code": { "@type": "MedicalCode", "code": "D000074822", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.300.150.800" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Refus de la vaccination", "alternateName": "Vaccination Refusal", "url": "https://questionsmedicales.fr/mesh/D000072758", "about": { "@type": "MedicalCondition", "name": "Refus de la vaccination", "code": { "@type": "MedicalCode", "code": "D000072758", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.300.150.800.750.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Réticence à l'égard de la vaccination", "alternateName": "Vaccination Hesitancy", "url": "https://questionsmedicales.fr/mesh/D000088823", "about": { "@type": "MedicalCondition", "name": "Réticence à l'égard de la vaccination", "code": { "@type": "MedicalCode", "code": "D000088823", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.300.150.800.750.500.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Refus du traitement", "alternateName": "Treatment Refusal", "code": { "@type": "MedicalCode", "code": "D016312", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Laura M Beskow", "url": "https://questionsmedicales.fr/author/Laura%20M%20Beskow", "affiliation": { "@type": "Organization", "name": "Center for Biomedical Ethics and Society." } }, { "@type": "Person", "name": "Daniel J Benedetti", "url": "https://questionsmedicales.fr/author/Daniel%20J%20Benedetti", "affiliation": { "@type": "Organization", "name": "Center for Biomedical Ethics and Society." } }, { "@type": "Person", "name": "Catherine M Hammack-Aviran", "url": "https://questionsmedicales.fr/author/Catherine%20M%20Hammack-Aviran", "affiliation": { "@type": "Organization", "name": "Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, TN, United States." } }, { "@type": "Person", "name": "Carolyn Diehl", "url": "https://questionsmedicales.fr/author/Carolyn%20Diehl", "affiliation": { "@type": "Organization", "name": "Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, TN, United States." } }, { "@type": "Person", "name": "Grégoire Moutel", "url": "https://questionsmedicales.fr/author/Gr%C3%A9goire%20Moutel", "affiliation": { "@type": "Organization", "name": "Équipe anticipe Inserm 1086, Université de Caen Normandie, esplanade de la Paix, 14032 Caen cedex 5, France; Service de médecine légale et droit de santé, CHU Caen, avenue de la Côte-de-Nacre, CS 30001, 14033 Caen cedex 9, France; Espace régional de réflexion éthique de Normandie, avenue de la Côte-de-Nacre, CS 30001, 14033 Caen cedex 9, France. Electronic address: gregoire.moutel@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Identification of hub genes through integrated single-cell and microarray transcriptome analysis in osteoarthritic meniscus.", "datePublished": "2024-10-23", "url": "https://questionsmedicales.fr/article/39438957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13018-024-05175-z" } }, { "@type": "ScholarlyArticle", "name": "Chromosome Microarray Analysis and Exome Sequencing: Implementation in Prenatal Diagnosis of Fetuses with Digestive System Malformations.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37895220", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes14101872" } }, { "@type": "ScholarlyArticle", "name": "Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results.", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36333674", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-022-05139-3" } }, { "@type": "ScholarlyArticle", "name": "Chromosomal microarray analysis supplements exome sequencing to diagnose children with suspected inborn errors of immunity.", "datePublished": "2023-05-05", "url": "https://questionsmedicales.fr/article/37215141", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1172004" } }, { "@type": "ScholarlyArticle", "name": "Contribution of chromosomal microarray analysis and next-generation sequencing to genetic diagnosis in fetuses with normal karyotype.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36316250", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jog.15486" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Prestations des soins de santé", "item": "https://questionsmedicales.fr/mesh/D003695" }, { "@type": "ListItem", "position": 4, "name": "Attitude envers la santé", "item": "https://questionsmedicales.fr/mesh/D001294" }, { "@type": "ListItem", "position": 5, "name": "Adhésion et observance thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D000074822" }, { "@type": "ListItem", "position": 6, "name": "Refus du traitement", "item": "https://questionsmedicales.fr/mesh/D016312" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Refus du traitement - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Refus du traitement", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Refus du traitement", "description": "Comment évaluer le refus de traitement chez un patient ?\nQuels outils peuvent aider à diagnostiquer le refus de traitement ?\nLe refus de traitement est-il un diagnostic médical ?\nQuels facteurs influencent le diagnostic du refus de traitement ?\nComment les professionnels de santé identifient-ils le refus ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Refus du traitement", "description": "Quels symptômes peuvent indiquer un refus de traitement ?\nLe refus de traitement peut-il causer des symptômes physiques ?\nComment le refus de traitement affecte-t-il la santé mentale ?\nLe refus de traitement est-il associé à des symptômes spécifiques ?\nQuels signes comportementaux révèlent un refus de traitement ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Refus du traitement", "description": "Comment prévenir le refus de traitement ?\nQuel rôle joue la communication dans la prévention du refus ?\nLes groupes de soutien peuvent-ils aider à prévenir le refus ?\nComment les antécédents médicaux influencent-ils le refus ?\nQuelles stratégies peuvent aider à prévenir le refus de traitement ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Refus du traitement", "description": "Quels traitements sont souvent refusés par les patients ?\nComment aborder un patient qui refuse un traitement ?\nQuels sont les risques de refuser un traitement ?\nLe refus de traitement peut-il être temporaire ?\nComment les médecins peuvent-ils réduire le refus de traitement ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Refus du traitement", "description": "Quelles complications peuvent résulter du refus de traitement ?\nLe refus de traitement peut-il affecter la famille ?\nComment le refus de traitement impacte-t-il le système de santé ?\nLe refus de traitement peut-il entraîner des complications psychologiques ?\nQuelles sont les conséquences à long terme du refus de traitement ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Refus du traitement", "description": "Quels facteurs de risque sont associés au refus de traitement ?\nL'âge influence-t-il le refus de traitement ?\nLe niveau d'éducation impacte-t-il le refus de traitement ?\nLes antécédents de maladie mentale influencent-ils le refus ?\nLes croyances religieuses peuvent-elles affecter le refus de traitement ?", "url": "https://questionsmedicales.fr/mesh/D016312?mesh_terms=Microarray+Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer le refus de traitement chez un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation implique des entretiens pour comprendre les raisons du refus et les croyances du patient." } }, { "@type": "Question", "name": "Quels outils peuvent aider à diagnostiquer le refus de traitement ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens structurés peuvent aider à identifier les motifs de refus." } }, { "@type": "Question", "name": "Le refus de traitement est-il un diagnostic médical ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, c'est un comportement qui peut être associé à divers diagnostics médicaux sous-jacents." } }, { "@type": "Question", "name": "Quels facteurs influencent le diagnostic du refus de traitement ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la culture, l'éducation, l'expérience personnelle et la compréhension de la maladie." } }, { "@type": "Question", "name": "Comment les professionnels de santé identifient-ils le refus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils observent les interactions, posent des questions ouvertes et évaluent les réponses du patient." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un refus de traitement ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de détresse, d'anxiété ou de résistance lors des consultations peuvent indiquer un refus." } }, { "@type": "Question", "name": "Le refus de traitement peut-il causer des symptômes physiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress lié au refus peut exacerber des symptômes physiques existants ou en créer de nouveaux." } }, { "@type": "Question", "name": "Comment le refus de traitement affecte-t-il la santé mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il peut entraîner une augmentation de l'anxiété, de la dépression et un sentiment d'impuissance." } }, { "@type": "Question", "name": "Le refus de traitement est-il associé à des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être lié à des symptômes de maladies chroniques non traitées, comme la douleur ou la fatigue." } }, { "@type": "Question", "name": "Quels signes comportementaux révèlent un refus de traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'évitement des consultations, le manque de suivi des prescriptions et des changements d'attitude sont des signes." } }, { "@type": "Question", "name": "Comment prévenir le refus de traitement ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation des patients sur leur maladie et les traitements disponibles peut réduire le refus." } }, { "@type": "Question", "name": "Quel rôle joue la communication dans la prévention du refus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une communication ouverte et empathique aide à établir la confiance et à réduire les craintes des patients." } }, { "@type": "Question", "name": "Les groupes de soutien peuvent-ils aider à prévenir le refus ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils offrent un espace pour partager des expériences et des informations, réduisant ainsi l'isolement." } }, { "@type": "Question", "name": "Comment les antécédents médicaux influencent-ils le refus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des expériences négatives passées avec des traitements peuvent augmenter la probabilité de refus futur." } }, { "@type": "Question", "name": "Quelles stratégies peuvent aider à prévenir le refus de traitement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Impliquer les patients dans le processus décisionnel et leur fournir des ressources éducatives sont efficaces." } }, { "@type": "Question", "name": "Quels traitements sont souvent refusés par les patients ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements comme la chimiothérapie, la radiothérapie ou les interventions chirurgicales sont souvent refusés." } }, { "@type": "Question", "name": "Comment aborder un patient qui refuse un traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel d'écouter ses préoccupations, d'expliquer les bénéfices et de respecter son choix." } }, { "@type": "Question", "name": "Quels sont les risques de refuser un traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le refus peut entraîner une aggravation de la maladie, des complications et une diminution de la qualité de vie." } }, { "@type": "Question", "name": "Le refus de traitement peut-il être temporaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent changer d'avis après avoir reçu plus d'informations ou de soutien." } }, { "@type": "Question", "name": "Comment les médecins peuvent-ils réduire le refus de traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En fournissant des informations claires, en établissant une relation de confiance et en impliquant le patient dans les décisions." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter du refus de traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la progression de la maladie, des hospitalisations fréquentes et des douleurs chroniques." } }, { "@type": "Question", "name": "Le refus de traitement peut-il affecter la famille ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cela peut entraîner du stress familial, des conflits et des préoccupations concernant la santé du patient." } }, { "@type": "Question", "name": "Comment le refus de traitement impacte-t-il le système de santé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Il peut augmenter les coûts de soins de santé en raison de complications et de traitements d'urgence nécessaires." } }, { "@type": "Question", "name": "Le refus de traitement peut-il entraîner des complications psychologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut provoquer des sentiments de culpabilité, d'anxiété et de dépression chez le patient." } }, { "@type": "Question", "name": "Quelles sont les conséquences à long terme du refus de traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure une détérioration de la santé physique et mentale et une qualité de vie réduite." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés au refus de traitement ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des croyances culturelles, un manque d'information et des expériences passées négatives." } }, { "@type": "Question", "name": "L'âge influence-t-il le refus de traitement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus susceptibles de refuser des traitements en raison de préoccupations liées aux effets secondaires." } }, { "@type": "Question", "name": "Le niveau d'éducation impacte-t-il le refus de traitement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible niveau d'éducation peut limiter la compréhension des traitements et augmenter le refus." } }, { "@type": "Question", "name": "Les antécédents de maladie mentale influencent-ils le refus ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients ayant des antécédents de maladie mentale peuvent avoir des réticences à accepter des traitements." } }, { "@type": "Question", "name": "Les croyances religieuses peuvent-elles affecter le refus de traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines croyances religieuses peuvent amener les patients à refuser des traitements médicaux." } } ] } ] }

Sources (10000 au total)

Identification of hub genes through integrated single-cell and microarray transcriptome analysis in osteoarthritic meniscus.

Osteoarthritis (OA) is marked by the progressive degradation of joint cartilage and subchondral bone. The precise molecular mechanisms driving meniscus deterioration in OA, especially at the single-ce... We analyzed two datasets from the GEO database, GSE220243 and GSE98918, focusing on meniscus tissue sequencing data from OA and non-OA patients. The standard Seurat procedure was employed to process s... After quality control, 34,763 cells from the OA patients and 34,145 cells from the healthy controls were analyzed. UMAP identified and SingleR annotated 14 cell clusters. The 10 largest cell clusters ... This research highlights crucial genes in the OA meniscus and uncovers their differing regulatory patterns between chondrocytes and non-chondrocytes. These findings enhance our understanding of the mo...

Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results.

Down syndrome (DS) is the most common congenital cause of intellectual disability and also leads to numerous metabolic and structural problems. This study aims to explore the application value of chro... The study recruited 1452 pregnant women with abnormal DS screening results including 493 with an enlarged nuchal translucency thickness (NT ≥ 2.5 mm) and 959 with an abnormal second-trimester maternal... CMA identified 74/1452 abnormal results, which was more efficient than karyotyping (51/1452, P < 0.05.) CMA is equivalent to traditional karyotyping for identifying aneuploidies. Compared to karyotypi... CMA and karyotyping have both advantages and disadvantages in prenatal diagnosis of pregnant women with abnormal DS screening results. However, there was not enough evidence to support routine CMA in ...

Chromosomal microarray analysis supplements exome sequencing to diagnose children with suspected inborn errors of immunity.

Though copy number variants (CNVs) have been suggested to play a significant role in inborn errors of immunity (IEI), the precise nature of this role remains largely unexplored. We sought to determine... We performed exome sequencing (ES) and CMA for 332 unrelated pediatric probands referred for evaluation of IEI. The analysis included primary, secondary, and incidental findings.... Of the 332 probands, 134 (40.4%) received molecular diagnoses. Of these, 116/134 (86.6%) were diagnosed by ES alone. An additional 15/134 (11.2%) were diagnosed by CMA alone, including two likely... Pairing ES and CMA can provide a comprehensive evaluation to clarify the complex factors that contribute to both immune and non-immune phenotypes. Such a combined approach to genetic testing helps unt...

Contribution of chromosomal microarray analysis and next-generation sequencing to genetic diagnosis in fetuses with normal karyotype.

The aim of this study was to investigate the contribution of chromosomal microarray analysis (CMA) and next-generation sequencing (NGS) to genetic diagnosis in fetuses with normal karyotype who underw... The results of invasive genetic testing performed at a tertiary center between September 2020 and March 2022 were retrospectively analyzed. Indications for invasive tests were classified as fetal stru... A total of 830 invasive tests were performed and aneuploidy was detected in 11.2% of the fetuses. CMA was performed in 465 fetuses with normal karyotype, and pCNVs were detected in 6.9%. pCNVs were de... pCNVs can be significantly detected not only in fetuses with structural malformations, but also in invasive testing with other indications. NGS significantly contributes to genetic diagnosis in fetuse...

Receiving uncertain results from prenatal chromosomal microarray analysis: Women's decisions on continuation or termination of pregnancy.

Chromosomal microarray analysis (CMA) may detect variants of uncertain clinical significance (VUS) and susceptibility loci (SL) with incomplete penetrance for neurodevelopmental disorders. This qualit... Semi-structured interviews were conducted with women who received a VUS and/or SL from prenatal CMA in the last 2-4 years and were analyzed using Grounded Theory.... The vast majority of women recalled being stressed by the findings. All women sought further advice and information to be able to decide whether to continue or terminate their pregnancy. The three pre... Although uncertain/probabilistic information commonly involves a psychological burden, it may also be perceived as valuable and actionable. Pre-test parental choice regarding the disclosure of such in...

Phenotypic findings and pregnancy outcomes of fetal rare autosomal aneuploidies detected using chromosomal microarray analysis.

Aneuploidies are the most common chromosomal abnormality and the main genetic cause of adverse pregnancy outcomes. Since numerous studies have focused on common trisomies, relatively little is known a... A total of 90 RAAs were detected, of which 83 cases were mosaic trisomies and 7 were non-mosaic trisomies. Chromosomes 16, 22, and 9 were identified as the major chromosomes involving RAAs. The four p... Variable phenotypes and outcomes were observed, which were highly heterogeneous in cases of prenatal RAAs. Thus, a cautious and comprehensive strategy should be implemented during prenatal counseling ...

Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.

Alzheimer's disease is a prevalent health problem with a heavy global burden. Definitely diagnosed by autopsy, the clear mechanism of Alzheimer's disease pathogenesis process needs to be illustrated. ... We attempted to discover the role of microRNA in Alzheimer's disease by microarray bioinformatics analysis using autopsy sample data from the GEO database. Temporal cortex samples were included in thi... After filtering out significantly differential expressed microRNAs and genes, enrichment analyses of both microRNAs and genes were conducted, respectively. Then, we constructed a transcription factor-... Hsa-miR-365b-5p act as a key target in Alzheimer's disease. It regulates Alzheimer's disease pathogenesis process via neuroinflammation, Wnt and oxidative stress pathway which provides a potential tar...